TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,639,000 | +69.0% | 150,259 | -6.7% | 0.08% | +70.2% |
Q2 2021 | $1,562,000 | +6.3% | 160,991 | +17.7% | 0.05% | -4.1% |
Q1 2021 | $1,469,000 | -26.4% | 136,785 | +0.7% | 0.05% | -39.5% |
Q4 2020 | $1,997,000 | -18.4% | 135,779 | -21.1% | 0.08% | -33.6% |
Q3 2020 | $2,447,000 | +70.8% | 172,145 | -2.8% | 0.12% | +62.7% |
Q2 2020 | $1,433,000 | – | 177,100 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |